Prospective randomized comparisons of ranitidine bismuth citrate (RBC) versus colloidal bismuth subcitrate (Denol)-based triple therapy for the treatment of H-pylori infection.

被引：0
|
作者：
Kung, NNS
Sung, JY
Yuen, WF
Li, TH
Ng, PW
Lai, WM
Leung, MF
机构：
[1] Chinese Univ Hong Kong, Hong Kong, Hong Kong
[2] United Christian Hosp, Dept Med, Hong Kong, Hong Kong
[3] United Christian Hosp, Dept Pathol, Hong Kong, Hong Kong
[4] United Christian Hosp, Dept Microbiol, Hong Kong, Hong Kong
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)80774-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G0780
引用
收藏
页码：A190 / A190
页数：1
相关论文
共 50 条
  • [21] Ranitidine bismuth citrate (RBC) and azithromycin (Az) based therapy for Helicobacter pylori infection in peptic ulcer patients
    Duvnjak, M
    Vucelic, B
    Katicic, M
    Krizman, I
    Culig, J
    Pavic-Sladoljev, D
    Naletilic, D
    [J]. GUT, 1999, 45 : A118 - A118
  • [22] Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection:: A review
    Gisbert, JP
    Pajares, JM
    Valle, J
    [J]. HELICOBACTER, 1999, 4 (01) : 58 - 66
  • [23] Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori
    Laine, L
    Estrada, R
    Trujillo, M
    Emami, S
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1997, 92 (12): : 2213 - 2215
  • [24] Ranitidine bismuth citrate (RBC) or omeprazole (O) with clarithromycin (C) and amoxycillin (A) for one week in the eradication of H-pylori
    Cabooter, M
    Dekkers, CPM
    Theodors, A
    Vanweerts, S
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A345 - A345
  • [25] Prospective open label trial of ranitidine bismuth citrate, metronidazole & tetracycline for 10 days in patients with H-pylori infection
    Barthel, JS
    King, PD
    Early, D
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A120 - A120
  • [26] Levofloxacin-vs. ranitidine bismuth citrate-containing therapy after H-pylori treatment failure
    Gisbert, Javier P.
    Gisbert, Jose Luis
    Marcos, Santiago
    Moreno-Otero, Ricardo
    Pajares, Jose Maria
    [J]. HELICOBACTER, 2007, 12 (01) : 68 - 73
  • [27] One-week ranitidine bismuth citrate (RBC) triple therapy versus proton-pump inhibitor (PPI) triple therapy for the treatment of H-pylori-associated duodenal ulcers
    Sung, JY
    Leung, WK
    Ling, TKW
    Yung, MY
    Chan, KL
    Lee, YT
    Chung, SCS
    Cheng, AFB
    [J]. GUT, 1997, 41 : A51 - A52
  • [28] A comparison of ranitidine bismuth citrate-clarithromycin (RBC-C) dual therapy vs. omeprazole, clarithromycin, amoxycillin (OCA) triple therapy given for 7 days in the treatment of H-pylori infection
    van Zanten, SJOV
    Chiba, N
    Barkun, AN
    Fallone, CA
    Farley, A
    Cockeram, A
    Dallaire, C
    Simms, L
    Nicholls, B
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A586 - A586
  • [29] Rescue therapy after H-pylori treatment failure:: Omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole
    Gisbert, JP
    Marcos, S
    Gisbert, JL
    Carpio, D
    Valle, J
    Cabrera, MM
    Cruzado, AI
    Garcia-Gravalos, R
    Pajares, JM
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A172 - A172
  • [30] Double therapy with ranitidine bismuth citrate (RBC) and clarithromycin during two weeks, has lower efficacy than triple therapy with RBC, clarithromycin and amoxicillin during one week in the eradication of H. pylori infection.
    Hergueta, P
    Rojas, M
    Romero, R
    Gomez, BJ
    Pellicer, FJ
    Herrerias, JM
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1245 - A1245
12345